Literature DB >> 8035018

Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction.

S Sei1, D E Kleiner, J B Kopp, R Chandra, P E Klotman, R Yarchoan, P A Pizzo, H Mitsuya.   

Abstract

The amount of human immunodeficiency virus type 1 (HIV-1) in various tissues was investigated by polymerase chain reaction (PCR) in 16 patients with end-stage HIV-1 infection and 7 patients with symptomatic but less advanced disease. During postmortem study of the 16 end-stage patients, HIV-1 DNA was found most often in lymph nodes and the spleen (both 100%), lung (93.8%), and colon (87.5%). Biopsied lymph nodes from the 7 symptomatic patients contained substantially higher copy numbers of HIV-1 RNA and DNA than did peripheral blood mononuclear cells (PBMC). Plasma viral RNA levels correlated significantly with the amount of HIV-1 RNA in PBMC (r2 = .86, P = .0025) but not with the level of viral RNA in lymph nodes in patients with symptomatic HIV-1 infection. These data suggest that although lymph nodes represent the main site for HIV-1 infection and replication, the level of circulating viral burden may not be solely determined by the magnitude of active HIV-1 replication in lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8035018     DOI: 10.1093/infdis/170.2.325

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  AIDS and the lung: update 1995. 4. Role of the human immunodeficiency virus within the lung.

Authors:  J R Clarke; D S Robinson; R J Coker; R F Miller; D M Mitchell
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

2.  In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues.

Authors:  J K Wong; C C Ignacio; F Torriani; D Havlir; N J Fitch; D D Richman
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.

Authors:  S Sei; Q E Yang; D O'Neill; K Yoshimura; K Nagashima; H Mitsuya
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity.

Authors:  Kalonji R Collins; Miguel E Quiñones-Mateu; Mianda Wu; Henry Luzze; John L Johnson; Christina Hirsch; Zahra Toossi; Eric J Arts
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 5.  Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies.

Authors:  O J Cohen; G Pantaleo; G K Lam; A S Fauci
Journal:  Springer Semin Immunopathol       Date:  1997

Review 6.  The role of viral dynamics in the pathogenesis of HIV disease and implications for antiviral therapy.

Authors:  D V Havlir; D D Richman
Journal:  Springer Semin Immunopathol       Date:  1997

7.  Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.

Authors:  Leondios G Kostrikis; Giota Touloumi; Rose Karanicolas; Nikos Pantazis; Cleo Anastassopoulou; Anastasia Karafoulidou; James J Goedert; Angelos Hatzakis
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 8.  Significance of CXCL12 in type 2 diabetes mellitus and its associated complications.

Authors:  Mojgan Noroozi Karimabad; Gholamhossein Hassanshahi
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.